Association of calcium supplement with risk of incident arrhythmia - 25/04/25

Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background and aims |
Calcium plays a crucial role in cardiac electrophysiology, but the association between calcium supplement and the risk of incident arrhythmia remains unclear.
Objective |
To investigate the relationship between habitual calcium supplement and incident risk of cardiac arrhythmia.
Methods |
We conducted a prospective study of 480,972 participants from the UK Biobank. Habitual calcium supplement was treated as the main exposure. The primary outcome was the incidence of arrhythmias, including atrial fibrillation/flutter (AF/AFL), ventricular arrhythmia (VA), and bradyarrhythmia. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results |
After a median follow-up of 11.69 years, 46,609 incident arrhythmia cases were documented, including 36,406 AF/AFL, 5,370 VA, and 14,226 bradyarrhythmia. After multivariable adjustment, calcium supplement was associated with an increased risk of total arrhythmias (HR 1.11, 95% CI 1.05–1.19), AF/AFL (HR 1.20, 95% CI 1.12–1.28), VA (HR 1.14, 95% CI 1.07–1.21), and bradyarrhythmia (HR 1.18, 95% CI 1.11–1.26). Significant interactions were observed between calcium supplement and estimated glomerular filtration rate, diabetes, cardiovascular disease, and polygenic risk score for AF (all p for interaction < 0.05).
Conclusions |
Calcium supplement was associated with an increased risk of incident arrhythmia. Careful evaluation of the potential arrhythmic risk is warranted when considering calcium supplement in individuals with clinical indications.
Le texte complet de cet article est disponible en PDF.Keywords : Calcium supplement, Atrial fibrillation, Ventricular arrhythmia, Bradyarrhythmia, Incident risk
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
